Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Pornography Abstinence and Nocturnal Erections in Adult Men

26. mai 2026 oppdatert av: Efforia, Inc

A Real-World Observational Study Evaluating the Effects of 30 Days of Pornography Abstinence on Nocturnal Penile Tumescence, Sexual Function, and Well-Being in Adult Men

The effects of pornography use on male sexual health remain uncertain, with mixed findings across existing literature and substantial variability at the individual level. This observational study is designed to help participants evaluate how a 30-day period of pornography abstinence affects their own sexual health and well-being, with a specific focus on nocturnal penile tumescence as a physiological biomarker.

Participants will complete a short baseline observation period during which they maintain their usual pornography consumption patterns, followed by a 30-day abstinence period. Objective nocturnal erection data will be collected using a connected wearable device, alongside validated self-report questionnaires assessing erectile function, sexual desire, mood, energy, and emotional well-being. Participants serve as their own control, allowing for within-person comparisons of outcomes before and during the abstinence period.

Studieoversikt

Status

Rekruttering

Forhold

Intervensjon / Behandling

Detaljert beskrivelse

This single-arm, real-world observational study evaluates the association between pornography abstinence and changes in nocturnal penile tumescence, sexual function, and psychosocial outcomes in adult men.

During an initial baseline phase, participants continue their typical pornography use while collecting objective nocturnal erection data and completing baseline questionnaires. Participants then enter a 30-day abstinence period, during which they attempt to refrain from pornography use. Abstinence adherence is self-reported, with lapses logged as observational data rather than protocol violations.

Nocturnal penile tumescence is assessed nightly using the Adam Sensor, a non-invasive wearable device that measures changes in penile circumference during sleep. Additional outcomes are assessed using validated questionnaires administered at baseline and at weekly intervals. The study is exploratory and signal-detecting in nature and is not designed to establish causality.

Study Design

Study Type: Observational

Study Design: Single-arm, within-participant comparison

Time Perspective: Prospective

Masking: None (Open Label)

Primary Purpose: Health outcomes assessment / signal detection

Additional information can be found at the study recruitment landing page here: https://app.efforia.com/30-day-tv-abstinence-challenge/

Studietype

Observasjonsmessig

Registrering (Antatt)

100

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

  • Forente stater
    • New York
      • New York, New York, Forente stater, 10003
        • Rekruttering
        • Efforia
        • Ta kontakt med:

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Ja

Prøvetakingsmetode

Ikke-sannsynlighetsprøve

Studiepopulasjon

Adult men who are interested in evaluating how a 30-day period of pornography abstinence may affect their sexual health, nocturnal erections, and overall well-being. Participants are self-selected volunteers who report current or recent pornography use, are able to attempt abstinence for the duration of the study, and are willing to use a non-invasive wearable device to collect nocturnal penile tumescence data and complete electronic questionnaires. The study population reflects a real-world, consumer-based sample rather than a clinically diagnosed population.

Beskrivelse

Inclusion Criteria:

  • Adult males of legal age of consent
  • Willingness to attempt pornography abstinence
  • Ability to use a wearable device during sleep
  • Ability to complete electronic surveys
  • Willingness to purchase the study device

Exclusion Criteria:

  • Have a history of significant sexual dysfunction requiring active medical treatment
  • Have current or uncontrolled mental health disorders
  • Have a history of addictive behaviors that may be exacerbated by abstinence
  • Are undergoing hormonal therapy or treatment affecting sexual function
  • Are experiencing unstable interpersonal or relationship stressors
  • Have significant concerns about privacy related to sexual health data
  • Have cultural or religious considerations that could cause distress

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

Kohorter og intervensjoner

Gruppe / Kohort
Intervensjon / Behandling
Single Arm longitudinal where participants act as their own control
Atferdsmessig: Pornography Abstinence
Participants will attempt to abstain from all pornography use for 30 consecutive days. Any deviations from abstinence are self-reported and logged for contextual analysis.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in Nocturnal Penile Tumescence
Tidsramme: Baseline Day to Day 38

Measure: Adam Sensor - Nocturnal Erection Tracking

Description:

Objective measurement of nocturnal penile tumescence, Frequency/Time nocturnal erections per night
Baseline Day to Day 38

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in Erectile Function
Tidsramme: Baseline to Day 38 after intervention

Measure: International Index of Erectile Function (IIEF-15)

Scale Range: 5-75 (higher scores indicate better erectile and sexual function)

Description:

Assesses erectile function, orgasmic function, sexual desire, intercourse satisfaction, and overall satisfaction.
Baseline to Day 38 after intervention
Change in Sexual Desire
Tidsramme: Baseline to Day 38 after intervention

Measure: Sexual Desire Inventory-2 (SDI-2)

Scale Range: 0-112 (higher scores indicate greater sexual desire)

Description:

Measures both dyadic and solitary sexual desire.
Baseline to Day 38 after intervention
Change in Pornography Consumption Patterns
Tidsramme: Baseline to Day 38 after intervention

Measure: Weekly Pornography Consumption Survey (custom self-report)

Scale: Frequency and duration categories (ordinal)

Description:

Tracks self-reported pornography use and abstinence adherence.
Baseline to Day 38 after intervention
Change in Mood, Energy, and Emotional Well-Being
Tidsramme: Baseline to Day 38 after intervention

Measure: Weekly Self-Assessment Check-In (custom)

Scale: 1-10 Likert-type scales (higher scores indicate more favorable states)

Description:

Assesses perceived mood, mental clarity, energy level, and emotional resilience.
Baseline to Day 38 after intervention

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Efforia, Inc

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

22. september 2025

Primær fullføring (Antatt)

22. september 2026

Studiet fullført (Antatt)

22. september 2026

Datoer for studieregistrering

Først innsendt

24. februar 2026

Først innsendt som oppfylte QC-kriteriene

26. mai 2026

Først lagt ut (Faktiske)

1. juni 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

1. juni 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

26. mai 2026

Sist bekreftet

1. mai 2026

Mer informasjon

Begreper knyttet til denne studien

Nøkkelord

Andre studie-ID-numre

  • 38321

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere